AARTIDRUGS — Aarti Drugs Balance Sheet
0.000.00%
- IN₹42.33bn
- IN₹48.25bn
- IN₹23.87bn
- 83
- 27
- 54
- 57
Annual balance sheet for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 215 | 342 | 197 | 198 | 226 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,193 | 8,325 | 8,659 | 7,052 | 7,619 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,568 | 13,934 | 14,918 | 13,207 | 13,384 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,844 | 7,665 | 8,622 | 10,351 | 11,891 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 17,660 | 22,080 | 24,214 | 24,324 | 25,747 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5,954 | 9,401 | 9,495 | 7,955 | 8,370 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 8,526 | 11,716 | 12,290 | 11,508 | 12,057 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 9,134 | 10,364 | 11,924 | 12,815 | 13,690 |
Total Liabilities & Shareholders' Equity | 17,660 | 22,080 | 24,214 | 24,324 | 25,747 |
Total Common Shares Outstanding |